Why a common asthma drug will now carry extra safety warnings about depression
- Written by Nial Wheate, Professor of Pharmaceutical Chemistry, Macquarie University

Australia’s Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included with the asthma and hay fever drug montelukast.
The warnings are for users and their families to look for signs of serious behaviour and mood-related changes, such as suicidal thoughts and depression. The new...